Clinical utility of biomarkers in premature atherosclerosis

Current Medicinal Chemistry

Volumn 19, Issue 16, 2012, Pages 2521-2533

  Kampoli, A M ^a   Tousoulis, D ^a   Papageorgiou, N ^a   Pallatza, Z ^a   Vogiatzi, G ^a   Briasoulis, A ^a   Androulakis, E ^a   Toutouzas, C ^a   Stougianos, P ^a   Tentolouris, C ^a   Stefanadis, C ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Atherosclerosis; Biomarker; Endothelium; Inflammation; Plaque; Sensitivity

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ALPHA INTERFERON; APOLIPOPROTEIN B; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CATHEPSIN; CYSTATIN C; FIBRIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE; N(G),N(G) DIMETHYLARGININE; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL PARAMETERS; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE COURSE; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; FLOW MEDIATED DILATION; HUMAN; INFECTION; INFLAMMATION; INTRAVASCULAR ULTRASOUND; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONHUMAN; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; RISK ASSESSMENT; SMOKING;

EID: 84860752182     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712800493039     Document Type: Article

References (123)

1. Roger, V.L.; Go, A.S.; Lloyd-Jones, D.M.; Adams, R.J.; Berry, J.D.; Brown, T.D.; Carnethon, M.R.; Dai, S.; de Simone, G.; Ford, E.S.; Fox, C.S.; Fullerton, H.J.; Gillespie, C; Greenlund, K.J.; Hailpern, S.M.; Heit, J.A.; Ho, P.M.; Howard, V.J.; Kissela, B.M.; Kittner, S.J.; Lackland, D.T.; Lichtman, J.H.; Lisabeth, L.D.; Makuc, D.M.; Marcus, G.M.; Marelli, A.; Matchar, D.B.;McDermott, M.M.; Meigs, J.B.; Moy, C.S.; Mozaffarian, D.; Mussolino, M.E.; Nichol, G.; Paynter, N.P.; Rosamond, W.D.; Sorlie, P.D.; Stafford, R.S.; Turan, T.N.; Turner, M.B.; Wong, N.D.; Wylie-Rosett, J. Heart Disease and Stroke Statistics-2011 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 2011, 123, e1-e192.
2. European cardiovascular disease statistics. 2008 edition. http://www.ehnheart.org/component/downloads/downloads/683.html (Accessed October 20, 2011).
3. Berenson, G.S.; Wattigney, W.A.; Bao, W.; Srinivasan, S.R.; Radhakrishnamurthy, B. Rationale to study the early natural history of heart disease: the Bogalusa Heart Study. Am. J. Med. Sci., 1995, 310 Suppl 1, S22-S28. (Pubitemid 26001212)
4. McGill, H.C. Jr.; McMahan, C.A.; Gidding, S.S. Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Circulation, 2008, 117, 1216-1227. (Pubitemid 351552015)
5. Makimattila, S.; Mäntysaari, M.; Groop, P.H.; Summanen, P.; Virkamäki, A.; Schlenzka, A.; Fagerudd, J.; Yki-Järvinen, H. Hyperreactivity to nitrovasodilators in forearm vasculature is related to autonomic dysfunction in insulin-dependent diabetes mellitus. Circulation, 1997, 95, 618-625. (Pubitemid 27063038)
6. Tintut, Y.; Patel, J.; Parhami, F.; Demer, L.L. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation, 2000, 102, 2636-2642.
7. Rajavashisth, T.; Qiao, J.H.; Tripathi, S.; Tripathi, J.; Mishra, N.; Hua, M.; Wang, X.P.; Loussararian, A.; Clinton, S.; Libby, P.; Lusis, A. Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest., 1998, 101, 2702-2710. (Pubitemid 28294579)
8. Iiyama, K.; Hajra, L.; Iiyama, M.; Li, H.; DiChiara, M.; Medoff, B.D.; Cybulsky, M.I. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ. Res., 1999, 85, 199-207. (Pubitemid 29343319)
9. Malik, I.; Danesh, J.; Whincup, P.; Bhatia, V.; Papacosta, O.; Walker, M.; Lennon, L.; Thomson, A.; Haskard, D. Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet, 2001, 358(9286), 971-6.
10. Bonin, P.D.; Fici, G.J.; Singh, J.P. Interleukin-1 promotes proliferation of vascular smooth muscle cells in coordination with PDGF or a monocyte derived growth factor. Exp. Cell. Res., 1989, 181(2), 475-82. (Pubitemid 19096413)
11. Reilly, C.F.; McFall, R.C. Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells. J. Biol. Chem., 1991, 266(15), 9419-27. (Pubitemid 21906673)
12. Busse, R.; Fleming, I. Endothelial Dysfunction in Atherosclerosis. J. Vasc. Res., 1996, 33, 181-194. (Pubitemid 26164469)
13. Victor, V.M.; Rocha, M.; Solá, E.; Bañuls, C.; Garcia-Malpartida, K.; Hernández-Mijares, A. Oxidative stress, endothelial dysfunction and atherosclerosis. Curr. Pharm. Des., 2009, 15(26), 2988-3002.
14. Davignon, J.; Ganz, P. Role of Endothelial Dysfunction in Atherosclerosis. Circulation, 2004, 109 [suppl III], III-27-III-32. (Pubitemid 38786440)
15. Furchgott, R.; Vanhoutte, P. Endothelium-derived relaxing and contracting factors FASEB. J., 1989, 3, 2007-2018. (Pubitemid 19187609)
16. Landmesser, U.; Hornig, B.; Drexler, H. Endothelial Function: A Critical Determinant in Atherosclerosis? Circulation, 2004, 109, II-27-II-33. (Pubitemid 38724153)
17. Feletou, M.; Vanhoutte, P. Endothelial dysfunction: a multifaceted disorder. Am. J. Physiol. Heart. Circ. Physiol., 2006, 291, H985-H1002. (Pubitemid 44343640)
18. Romano, M.; Mezzetti, A.; Marulli, C.; Ciabattoni, G.; Febo, F.; Di Ienno, S.; Roccaforte, S.; Vigneri, S.; Nubile, G.; Milani, M.; Daví, G. Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide. J. Invest. Med., 2000, 48, 183-189.
19. Yang, Z.; Ming, X. Recent Advances in Understanding Endothelial Dysfunction in Atherosclerosis. CM & R., 2006, 4(1), 53-65.
20. Goligorsky, M. Endothelial cell dysfunction: can't live with it, how to live without it. Am. J. Physiol. Renal. Physiol., 2005, 288, F871-F880. (Pubitemid 40569751)
21. Koba, S.; Hirano, T. Dyslipidemia and atherosclerosis. Nihon. Rinsho., 2011, 69(1), 138-43.
22. Prasad, A.; Zhu, J.; Halcox, J.P.; Waclawiw, M.A.; Epstein, S.E.; Quyyumi, A.A. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation, 2002, 106(2), 184-90. (Pubitemid 34761297)
23. Gabrielli, M.; Santarelli, L.; Gasbarrini, A. Role for chronic infections in atherosclerosis? Circulation, 2002, 106(7), e32.
24. Mayr, M.; Kiechl, S.; Willeit, J.; Wick, G.; Xu, Q. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heatshock protein 60 and carotid or femoral atherosclerosis. Circulation, 2000, 102(8), 833-9.
25. Jacob, H.S.; Visser, M.; Key, N.S.; Goodman, J.L.; Moldow, C.F.; Vercellotti, G.M. Herpes virus infection of endothelium: new insights into atherosclerosis. Trans. Am. Clin. Climatol. Assoc., 1992, 103, 95-104.
26. Chiu, B.; Viira, E.; Tucker, W.; Fong, I.W. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation, 1997, 96(7), 2144-8. (Pubitemid 27425815)
27. Celermajer, D.S.; Sorensen, K.E.; Georgakopoulos, D.; Bull, C.; Thomas, O.; Robinson, J.; Deanfield, J.E. Cigarette smoking is associated with doserelated and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation, 1993, 88, 2149-2155. (Pubitemid 23326094)
28. Tanriverdi, H.; Evrengul, H.; Kuru, O.; Tanriverdi, S.; Seleci, D.; Enli, Y.; Kaftan, H.A.; Kilic, M. Cigarette smoking induced oxidative stress may impair endothelial function and coronary blood flow in angiographically normal coronary arteries. Circ. J., 2006, 70(5), 593-9.
29. Noma, K.; Goto, C.; Nishioka, K.; Hara, K.; Kimura, M.; Umemura, T.; Jitsuiki, D.; Nakagawa, K.; Oshima, T.; Chayama, K.; Yoshizumi, M.; Higashi, Y. .Smoking, endothelial function, and Rho-kinase in humans. Arterioscler. Thromb. Vasc. Biol., 2005, 25(12), 2630-5. (Pubitemid 43732289)
30. Holay, M.P.; Paunikar, N.P.; Joshi, P.P.; Sahasrabhojney, V.S.; Tankhiwale, S.R. Effect of passive smoking on endothelial function in: healthy adults. J. Assoc. Physicians. India., 2004, 52, 114-7. (Pubitemid 44194610)
31. Woo, K.S.; Chook, P.; Leong, H.C.; Huang, X.S.; Celermajer, D.S. The impact of heavy passive smoking on arterial endothelial function in modernized Chinese. J. Am. Coll. Cardiol., 2000, 36(4), 1228-32.
32. Davis, J.W.; Shelton, L.; Watanabe, I.S.; Arnold, J. Passive smoking affects endothelium and platelets. Arch. Intern. Med., 1989, 149(2), 386-9. (Pubitemid 19058524)
33. Davis, J.W. Some acute effects of smoking on endothelial cells and platelets. Adv. Exp. Med. Biol., 1990, 273, 107-18.
34. Blann, A.D.; Kirkpatrick, U.; Devine, C.; Naser, S.; McCollum, C.N. The influence of acute smoking on leucocytes, platelets and the endothelium. Atherosclerosis, 1998, 141(1), 133-9. (Pubitemid 28539424)
35. Miller, E.A.; Pankow, J.S.; Millikan, R.C.; Bray, MS, Ballantyne, C.M.; Bell, D.A.; Heiss, G.; Li, R. Glutathione-S-transferase genotypes, smoking, and their association with markers of inflammation, hemostasis, and endothelial function: the atherosclerosis risk in communities (ARIC) study. Atherosclerosis, 2003, 171(2), 265-72. (Pubitemid 37486079)
36. Morrow, J.D.; Frei, B.; Longmire, A.W.; Gaziano, J.M.; Lynch, S.M.; Shyr, Y.; Strauss, W.E.; Oates, J.A.; Roberts, L.J. 2nd. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N. Engl. J. Med., 1995, 332, 1198-1203.
37. Kampoli, A.M.; Tousoulis, D., Papageorgiou, N., Stefanadis, C. In: Risk Factors and Vascular Endothelium; Tousoulis, d.; Stefanadis, C.; Ed.; Nova Science Publishers, V: New York, 2011; pp 124-161.
38. Tousoulis, D.; Kampoli, A.M.; Papageorgiou, N.; Papaoikonomou, S.; Antoniades, C.; Stefanadis, C. The impact of diabetes mellitus on coronary artery disease: new therapeutic approaches. Curr. Pharm. Des., 2009, 15(1), 2037-48.
39. Kampoli, A.M.; Tousoulis, D.; Marinou, K.; Siasos, G.; Stefanadis, C. Vascular Effects of Diabetes Mellitus. Vascular disease prevention, 2009, Volume 6, pp.85-90.
40. Kampoli, A.M.; Tousoulis, D.; Antoniades, C.; Siasos, G.; Stefanadis, C. Biomarkers of premature atherosclerosis. Trends. Mol. Med., 2009, 15(7), 323-32.
41. Pearson, T.A.; Mensah, G.A.; Alexander, R.W.; Anderson, J.L.; Cannon, R.O. 3rd.; Criqui, M.; Fadl, Y.Y.; Fortmann, S.P.; Hong, Y.; Myers, G.L.; Rifai, N.; Smith, S.C. Jr.; Taubert, K.; Tracy, R.P.; Vinicor, F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 2003, 107, 499-511. (Pubitemid 36158056)
42. Koenig, W.; Löwel, H.; Baumert, J.; Meisinger, C. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation, 2004, 109, 1349-1353. (Pubitemid 38387819)
43. Cushman, M.; Arnold, A.M.; Psaty, B.M.; Manolio, T.A.; Kuller, L.H.; Burke, G.L.; Polak, J.F.; Tracy, R.P. C-reactive protein and the 10-year incedence of coronary heart disease in older men and women: the cardiovascular health study. Circulation, 2005, 112, 25-31. (Pubitemid 40962565)
44. Ridker, P.M.; Rifai, N.; Rose, L.; Buring, J.E.; Cook, N.R. Comparison of Creactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med., 2002, 347, 1557-65. (Pubitemid 35315836)
45. Atabek, M.E.; Pirgon, O.; Kurtoglu, S.; Imamoglu, H. Evidence for an association between type 1 diabetes and premature carotid atherosclerosis in childhood. Pediatr. Cardiol., 2006, 27(4), 428-33. (Pubitemid 44222394)
46. Fragakis, N.; Ioannidou, E.; Bounda, A.; Theodoridou, S.; Klonizakis, P.; Garipidou, V. Increased levels of proinflammatory cytokines in children with family history of coronary artery disease. Clin. Cardiol., 2010, 33(4), E6-10.
47. Khan, D.A.; Ansari, W.M.; Khan, F.A. Pro/anti-inflammatory cytokines in the pathogenesis of premature coronary artery disease. J. Interferon. Cytokine. Res., 2011, 31(7), 561-7.
48. Thacker, S.G.; Berthier, C.C.; Mattinzoli, D.; Rastaldi, M.P.; Kretzler, M.; Kaplan, M.J. The detrimental effects of IFN-a on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction. J. Immunol., 2010, 185(7), 4457-69.
49. Blankenberg, S.; Luc, G.; Ducimetiere, P.; Arveiler, D.; Ferrieres, J.; Amouyel, P.; Evans, A.; Cambien, F.; Tiret, L. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation, 2003, 108, 2453-2459. (Pubitemid 37444405)
50. Tiret, L.; Godefroy, T.; Lubos, E.; Nicaud, V.; Tregouet, D.A.; Barbaux, S.; Schnabel, R.; Bickel, C.; Espinola-Klein, C.; Poirier, O.; Perret, C.; Münzel, T.; Rupprecht, H.J.; Lackner, K.; Cambien, F.; Blankenberg, S. Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation, 2005, 112, 643-650. (Pubitemid 41099042)
51. Koenig, W.; Khuseyinova, N.; Baumert, J.; Thorand, B.; Loewel, H.; Chambless, L.; Meisinger, C.; Schneider, A.; Martin, S.; Kolb, H.; Herder, C. Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women. Results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002. Arterioscler. Thromb. Vasc. Biol., 2006, 26, 2745-2751.
52. Thompson, S.R.; McCaskie, P.A.; Beilby, J.P.; Hung, J.; Jennens, M.; Chapman, C.; Thompson, P.; Humphries, S.E. IL18 haplotypes are associated with serum IL-18 concentrations in a population-based study and a cohort of individuals with premature coronary heart disease. Clin. Chem., 2007, 53(12), 2078-85. (Pubitemid 350197290)
53. Judkin, J.S.; Kumari, M.; Humphries, S.E.; Mohamed-Ali, V. Inflammation, obesity, stress and coronary heart disease : is interleukin-6 the link ? Atherosclerosis, 2000, 148, 209-214. (Pubitemid 30064452)
54. Maitra, A.; Shanker, J.; Dash, D.; John, S.; Sannappa, P.R.; Rao, V.S.; Ramanna, J.K.; Kakkar, V.V. Polymorphisms in the IL6 gene in Asian Indian families with premature coronary artery disease-the Indian Atherosclerosis Research Study. Thromb. Haemost., 2008, 99(5), 944-50. (Pubitemid 351705313)
55. Rho, Y.H.; Chung, C.P.; Oeser, A.; Solus, J.; Raggi, P.; Gebretsadik, T.; Shintani, A.; Stein, C.M. Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus. J. Rheumatol., 2008, 35(9), 1789-94.
56. Narverud, I.; Ueland, T.; Nenseter, M.S.; Retterst?l, K.; Telle-Hansen, V.H.; Halvorsen, B.; Ose, L.; Aukrust, P.; Holven, K.B. Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor a system and interleukin-10. Atherosclerosis, 2011, 214(1), 163-8.
57. Ikewaki, K.; Matsunaga, A.; Han, H.; Watanabe, H.; Endo, A.; Tohyama, J.; Kuno, M.; Mogi, J.; Sugimoto, K.; Tada, N.; Sasaki, J.; Mochizuki, S. A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease. Atherosclerosis, 2004, 172(1), 39-45. (Pubitemid 38058599)
58. Hovingh, G.K.; Brownlie, A.; Bisoendial, R.J.; Dube, M.P.; Levels, J.H.; Petersen, W.; Dullaart, R.P.; Stroes, E.S.; Zwinderman, A.H.; de Groot, E.; Hayden, M.R.; Kuivenhoven, J.A.; Kastelein, J.J. A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease. J. Am. Coll. Cardiol., 2004, 44(7), 1429-35. (Pubitemid 39303944)
59. Ikewaki, K.; Schaefer, J.R.; Frischmann, M.E.; Okubo, K.; Hosoya, T.; Mochizuki, S.; Dieplinger, B.; Trenkwalder, E.; Schweer, H.; Kronenberg, F.; Koenig, P.; Dieplinger, H. Delayed in vivo catabolism of intermediatedensity lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2005, 25(12), 2615-22. (Pubitemid 43732287)
60. Bara, L.; Nicaud, V.; Tiret, L.; Cambien, F.; Samama, M.M. Expression of a paternal history of premature myocardial infarction on fibrinogen, factor VIIC and PAI-1 in European offspring-the EARS study. European Atherosclerosis Research Study Group. Thromb. Haemost., 1994, 71(4), 434-40. (Pubitemid 24100667)
61. Collet, J.P.; Allali, Y.; Lesty, C.; Tanguy, M.L.; Silvain, J.; Ankri, A.; Blanchet, B.; Dumaine, R.; Gianetti, J.; Payot, L.; Weisel, J.W.; Montalescot, G. Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis. Arterioscler. Thromb. Vasc. Biol., 2006, 26(11), 2567-73. (Pubitemid 44607482)
62. Woo, K.S.; Qiao, M.; Chook, P.; Poon, P.Y.; Chan, A.K.; Lau, J.T.; Fung, K.P.; Woo, J.L. Homocysteine, endothelial dysfunction, and coronary artery disease: emerging strategy for secondary prevention. J. Card. Surg., 2002, 17(5), 432-5. (Pubitemid 36250330)
63. Taraboanta, C.; Wu, E.; Lear, S.; DiPalma, S.; Hill, J.; Mancini, G.B.; Frohlich, J. Subclinical atherosclerosis in subjects with family history of premature coronary artery disease. Am. Heart. J., 2008, 155(6), 1020-1026.e1.
64. Sadeghian, S.; Fallahi, F.; Salarifar, M.; Davoodi, G.; Mahmoodian, M.; Fallah, N.; Darvish, S.; Karimi, A.; Tehran Heart Center. Homocysteine, vitamin B12 and folate levels in premature coronary artery disease. BMC. Cardiovasc. Disord., 2006, 6, 38.
65. Colley, K.J.; Wolfert, R.L.; Cobble, M.E. Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovascular risk. EPMA. J., 2011, 2(1), 27-38.
66. Ballantyne, C.M.; Hoogeveen, R.C.; Bang, H.; Coresh, J.; Folsom, A.R.; Heiss, G.; Sharrett, A.R. Lipoprotein-associated phospholipase A2, highsensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation, 2004, 109, 837-842. (Pubitemid 38252734)
67. Ballantyne, C.M.; Hoogeveen, R.C.; Bang, H.; Coresh, J.; Folsom, A.R.; Chambless, L.E.; Myerson, M.; Wu, K.K.; Sharrett, A.R.; Boerwinkle, E. Lipoprotein-associated phospholipase A2, highsensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Arch. Intern. Med., 2005, 165, 2479-2484. (Pubitemid 41720009)
68. Garza, C.A.; Montori, V.M.; McConnell, J.P.; Somers, V.K.; Kullo, I.J.; Lopez-Jimenez, F. Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review. Mayo. Clin. Proc., 2007, 82, 159-165. (Pubitemid 46198473)
69. Corson, M.A.; Jones, P.H.; Davidson, M.H. Review of the evidence for the clinical utility of lipoproteinassociated phospholipase A2 as a cardiovascular risk marker. Am. J. Cardiol., 2008, 101, 41F-50F.
70. Ali, M.; Madjid, M. Lipoprotein-associated phospholipase A2: a cardiovascular risk predictor and a potential therapeutic target. Future. Cardiol., 2009, 5, 159-173.
71. Tsikas, D.; Böger, R.H.; Sandmann, J.; Bode-Böger, S.M.; Frölich, J.C. Hypothesis: Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox. FEBS. Lett., 2000, 23810, 1-3.
72. Faraci, F.M.; Brian, J.E.J.; Heistad, D.D. Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase. Am. J. Physiol., 1995, 269, H1522-H1527. (Pubitemid 3005958)
73. Paravicini, T.M.; Miller, A.A.; Drummond, G.R.; Sobey, C.G. Flow-induced cerebral vasodilatation in vivo involves activation of phosphatidylinositol-3 kinase, NADPH-oxidase, and nitric oxide synthase. J. Cereb. Blood. Flow. Metab., 2006, 26(6), 836-45.
74. Ayer, J.G.; Harmer, J.A.; Nakhla, S.; Xuan, W.; Ng, M.K.; Raitakari, O.T.; Marks, G.B.; Celermajer, D.S. HDL-cholesterol, blood pressure, and asymmetric dimethylarginine are significantly associated with arterial wall thickness in children. Arterioscler. Thromb. Vasc. Biol., 2009, 29(6), 943-9.
75. Perna, M.; Roman, M.J.; Alpert, D.R.; Crow, M.K.; Lockshin, M.D.; Sammaritano, L.; Devereux, R.B.; Cooke, J.P.; Salmon, J.E. Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients. Arthritis. Rheum., 2010, 62(6), 1718-22.
76. Böger, R.H. In: Risk Factors and Vascular Endothelium; Dimitris Tousoulis and Christodoulos Stefanadis, Ed.; Nova Science Publishers, V; New York, 2011, pp 277-295.
77. Lau, D.; Baldus, S. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol. Ther., 2006, 111, 16-26. (Pubitemid 43765542)
78. Baldus, S.; Eiserich, J.P.; Mani, A.; Castro, L.; Figueroa, M.; Chumley, P.; Ma, W.; Tousson, A.; White, C.R.; Bullard, D.C.; Brennan, M.L.; Lusis, A.J.; Moore, K.P.; Freeman, B.A. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J. Clin. Invest., 2001, 108, 1859-70.
79. Baldus, S.; Heitzer, T.; Eiserich, J.P.; Lau, D.; Mollnau, H.; Ortak, M.; Petri, S.; Goldmann, B.; Duchstein, H.J.; Berger, J.; Helmchen, U.; Freeman, B.A.; Meinertz, T.; Münzel, T. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free. Radic. Biol. Med., 2004, 37, 902-11. (Pubitemid 39078559)
80. Eiserich, J.P.; Baldus, S.; Brennan, M.L.; Ma, W.; Zhang, C.; Tousson, A.; Castro, L.; Lusis, A.J.; Nauseef, W.M.; White, C.R.; Freeman, B.A. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science, 2002, 296, 2391-4. (Pubitemid 34734213)
81. Baldus, S.; Rudolph, V.; Roiss, M.; Ito, W.D.; Rudolph, T.K.; Eiserich, J.P.; Sydow, K.; Lau, D.; Szöcs, K.; Klinke, A.; Kubala, L.; Berglund, L.; Schrepfer, S.; Deuse, T.; Haddad, M.; Risius, T.; Klemm, H.; Reichenspurner, H.C.; Meinertz, T.; Heitzer, T. Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation, 2006, 113, 1871-8. (Pubitemid 43739399)
82. Rudolph, V.; Rudolph, T.K.; Schopfer, F.J.; Ito, W.D.; Rudolph, T.K.; Eiserich, J.P.; Sydow, K.; Lau, D.; Szöcs, K.; Klinke, A.; Kubala, L.; Berglund, L.; Schrepfer, S.; Deuse, T.; Haddad, M.; Risius, T.; Klemm, H.; Reichenspurner, H.C.; Meinertz, T.; Heitzer, T. Bivalirudin decreases NO bioavailability by vascular immobilization of myeloperoxidase. J. Pharmacol. Exp. Ther., 2008, 327, 324-31.
83. Rudolph, T.K.; Rudolph, V.; Witte, A.; Klinke, A.; Szoecs, K.; Lau, D.; Heitzer, T.; Meinertz, T.; Baldus, S. Liberation of vessel adherent myeloperoxidase by enoxaparin improves endothelial function. Int. J. Cardiol., 2010, 140, 42-7.
84. Gu, F.F.; Lü, S.Z.; Chen, Y.D.; Zhou, Y.J.; Song, X.T.; Jin, Z.N.; Liu, H. Relationship between plasma cathepsin S and cystatin C levels and coronary plaque morphology of mild to moderate lesions: an in vivo study using intravascular ultrasound. Chin. Med. J. (Engl)., 2009, 122(23), 2820-6.
85. Punturieri, A.; Filippov, S.; Allen, E.; Caras, I.; Murray, R.; Reddy, V.; Weiss, S.J. Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J. Exp. Med., 2000, 192, 789-799.
86. Sukhova, G.K.; Shi, G.P.; Simon, D.I.; Chapman, H.A.; Libby, P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J. Clin. Invest., 1998, 102, 576-583. (Pubitemid 28376160)
87. Rodgers, K.J.; Watkins, D.J.; Miller, A.L.; Chan, P.Y.; Karanam, S.; Brissette, W.H.; Long, C.J.; Jackson, C.L. Destabilizing role of cathepsin S in murine atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol., 2006, 26, 851-856. (Pubitemid 43732162)
88. Liu, J.; Sukhova, G.K.; Sun, J.S.; Xu, W.H.; Libby, P.; Shi, G.P. Lysosomal cysteine proteases in atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2004, 24, 1359-1366. (Pubitemid 39056073)
89. Dubin, G. Proteinaceous cysteine protease inhibitors. Cell. Mol. Life. Sci., 2005, 62, 653-669.
90. Shi, G.P.; Sukhova, G.K.; Grubb, A.; Ducharme, A.; Rhode, L.H.; Lee, R.T.; Ridker, P.M.; Libby, P.; Chapman, H.A. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J. Clin. Invest., 1999, 104, 1191-1197. (Pubitemid 29536290)
91. Lindstedt, L.; Lee, M.; Öörni, K.; Bromme, D.; Kovanen, P.T. Cathepsins F and S block HDL3-induced cholesterol efflux from macrophage foam cells. Biochem. Biophys. Res. Commun., 2003, 312, 1019-1024. (Pubitemid 37490917)
92. Deanfield, J.E.; Halcox, J.P.; Rabelink, T.J. Endothelial function and dysfunction: testing and clinical relevance. Circulation, 2007, 115, 1285-95. (Pubitemid 46594773)
93. Celermajer, D.S. Brachial artery FMD with 5-minute distal cuff occlusion-a useful pathophysiological test after all! J. Appl. Physiol., 2005, 99, 1619.
94. Doshi, S.N.; Naka, K.K.; Payne, N.; Jones, C.J.; Ashton, M.; Lewis, M.J.; Goodfellow, J. Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. Clin. Sci. (Lond)., 2001, 101, 629-35. (Pubitemid 33135344)
95. Ghosh, P.; Kumar, A.; Kumar, S.; Aggarwal, A.; Sinha, N.; Misra, R. Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus. Clin. Rheumatol., 2009, 28(11), 1259-65.
96. Södergren, A.; Karp, K.; Boman, K.; Eriksson, C.; Lundström, E.; Smedby, T.; Söderlund, L.; Rantapää-Dahlqvist, S.; Wållberg-Jonsson, S. Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness. Arthritis. Res. Ther., 2010, 12(4), R158.
97. Brodmann, M.; Lipp, R.W.; Passath, A.; Seinost, G.; Pabst, E.; Pilger, E. The role of 2-F-18-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology, 2004, 43, 241-242. (Pubitemid 38219684)
98. Hara, M.; Goodman, P.C.; Leder, R.A. FDG-PET finding in earlyphase Takayasu arteritis. J. Comput. Assist. Tomogr., 1999, 23, 16-18. (Pubitemid 29095460)
99. Kumar, R.; Chauhan, A.; Zhuang, H.; Chandra, P.; Alavi, A. Assessment of therapy response by FDG-PET in infection and inflammation. PET. Clinics., 2006, 2, 191-198.
100. Tamaki, N. Myocardial Tomography using Technitium-99m-Tetrofosmin to evaluate coronary artery disease. J. Nucl. Med., 1994, 35, 594-600. (Pubitemid 24114557)
101. Nazeri, I.; Shahabi, P.; Tehrai, M.; Sharif-Kashani, B.; Nazeri, A. Impact of calcification on diagnostic accuracy of 64-slice spiral computed tomography for detecting coronary artery disease: a single center experience. Arch. Iran. Med., 2010, 13(5), 373-83.
102. Achenbach, S. Computed tomography coronary angiography. J. Am. Coll. Cardiol., 2006, 48, 1919-1928. (Pubitemid 44738433)
103. Hoffmann, U.; Moselewski, F.; Cury, R.C.; Ferencik, M.; Jang, I.K.; Diaz, L.J.; Abbara, S.; Brady, T.J.; Achenbach, S. Predictive value of 16-slice multidetector spiral computed tomography to detect significant obstructive coronary artery disease in patients at high risk for coronary artery disease. Patient-versus segment-based analysis. Circulation, 2004, 110, 2638-2643. (Pubitemid 39453013)
104. Hoffmann, M.H.; Shi, H.; Schmitz, B.L.; Schmid, F.T.; Lieberknecht, M.; Schulze, R.; Ludwig, B.; Kroschel, U.; Jahnke, N.; Haerer, W.; Brambs, H.J.; Aschoff, A.J. Noninvasive coronary angiography with multislice computed angiography. JAMA., 2005, 293, 2471-2478. (Pubitemid 40705728)
105. Mollet, N.R.; Cademartiri, F.; Krestin, G.P.; McFadden, E.P.; Arampatzis, C.A.; Serruys, P.W.; de Feyter, P.J. Improved diagnostic accuracy with 16-row multi-slice computed tomography coronary angiography. J. Am. Coll. Cardiol., 2005, 45, 128-132. (Pubitemid 40052038)
106. Reant, P.; Brunot, S.; Latte, S.; Serri, K.; Leroux, L.; Corneloup, O.; Iriart, X.; Coste, P.; Dos Santos, P.; Roudaut, R.; Laurent, F. Predictive value of noninvasive coronary angiography with multidetector computed tomography to detect significant coronary stenosis before valve surgery. Am. J. Cardiol., 2006, 97, 1506-1510.
107. Yamamoto, H.; Ohashi, N.; Ishibashi, K.; Utsunomiya, H.; Kunita, E.; Oka, T.; Horiguchi, J.; Kihara, Y. Coronary calcium score as a predictor for coronary artery disease and cardiac events in Japanese high-risk patients. Circ. J., 2011, 75(10), 2424-31.
108. Raff, G.L.; Gallagher, M.J.; O'Neill, W.W.; Goldstein, J.A. Diagnostic accuracy of noninvasive coronary angiography using 64-slice spiral computed tomography. Am. Coll. Cardiol., 2005, 46, 522-527.
109. Rumberger, J.A.; Simons, D.B.; Fitzpatrick, L.A.; Sheedy, P.F.; Schwartz, R.S. Coronary atherosclerotic plaque area: A histopathologic correlative study. Circulation, 1995, 92, 2157-2162.
110. Sangiorgi, G.; Rumberger, J.A.; Severson, A.; Edwards, W.D.; Gregoire, J.; Fitzpatric, L.A.; Schwartz, R.S. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: A histologic study of 723 coronary artery segments using nondecalcifying methodology. J. Am. Coll. Cardiol., 1998, 31, 126-133. (Pubitemid 28064732)
111. Iijima, K.; Akishita, M.; Ouchi, Y. Coronary artery calcification and cerebral small vessel disease. Circ. J., 2011, 75, 272-273.
112. Budoff, M.J.; Shaw, L.J.; Liu, S.T.; Weinstein, S.R.; Mosler, T.P.; Tseng, P.H.; Flores, F.R.; Callister, T.Q.; Raggi, P.; Berman, D.S. Long-term prognosis associated with coronary calcification: Observations from a registry of 25,253 patients. J. Am. Coll. Cardiol., 2007, 49, 1860-1870. (Pubitemid 46661110)
113. Raggi, P.; Gongora, M.C.; Gopal, A.; Callister, T.Q.; Budoff, M.; Shaw, L.J. Coronary artery calcium to predict all-cause mortality in elderly men and women. J. Am. Coll. Cardiol., 2008, 52, 17-23. (Pubitemid 351858598)
114. Detrano, R.; Guerci, A.D.; Carr, J.J.; Bild, D.E.; Burke, G.; Folsom, A.R.; Liu, K.; Shea, S.; Szklo, M.; Bluemke, D.A.; O'Leary, D.H.; Tracy, R.; Watson, K.; Wong, N.D.; Kronmal, R.A. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N. Engl. J. Med., 2008, 358, 1336-1345. (Pubitemid 351468410)
115. Patel, M.J.; de Lemos, J.A.; McGuire, D.K.; See, R.; Lindsey, J.B.; Murphy, S.A.; Grundy, S.M.; Khera, A. Evaluation of coronary artery calcium screening strategies focused on risk categories: The Dallas Heart Study. Am. Heart. J., 2009, 157, 1001-1009.
116. Nair, A.; Margolis, M.P.; Kuban, B.D.; Vince, D.G. Automated coronary plaque characterization with intravascular ultrasound backscatter: Ex vivo validation. Euro. Intervention., 2007, 3, 113-120.
117. Diethrich, E.B.; Margolis, P.M.; Reid, D.B.; Burke, A.; Ramaiah, V.; Rodriguez-Lopez, J.A.; Wheatley, G.; Olsen, D.; Virmani, R. Virtual histology intravascular ultrasound assessment of carotid artery disease: The Carotid Artery Plaque Virtual Histology Evaluation (CAPITAL) study. J. Endovasc. Ther., 2007, 14, 676-686. (Pubitemid 47598194)
118. Arnett, E.N.; Isner, J.M.; Redwood, D.R.; Kent, K.M.; Baker, W.P.; Ackerstein, H.; Roberts, W.C. Coronary artery narrowing in coronary heart disease: Comparison of cineangiographic and necropsy findings. Ann. Intern. Med., 1979, 91, 350-356. (Pubitemid 10220772)
119. Fisher, L.D.; Judkins, M.P.; Lesperance, J.; Cameron, A.; Swaye, P.; Ryan, T.; Maynard, C.; Bourassa, M.; Kennedy, J.W.; Gosselin, A.; Kemp, H.; Faxon, D.; Wexler, L.; Davis, K.B. Reproducibility of coronary arteriographic reading in the coronary artery surgery study (CASS). Cathet. Cardiovasc. Diagn., 1982, 8, 565-75. (Pubitemid 13170436)
120. Nissen, S.E.; Gurley, J.C.; Grines, C.L.; Grines, C.L.; Booth, D.C.; McClure, R.; Berk, M.; Fischer, C.; DiMaria, A.N. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation, 1991, 84, 1087-1099.
121. Mintz, G.S.; Painter, J.A.; Pichard, A.D.; Kent, K.M.; Satler, L.F.; Popma, J.J.; Chuang, Y.C.; Bucher, T.A.; Sokolowicz, L.E.; Leon, M.B. Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J. Am. Coll. Cardiol., 1995, 25, 1479-85.
122. Alfonso, F.; Macaya, C.; Goicolea, J.; Iñiguez, A.; Hernandez, R.; Zamorano, J.; Perez-Vizcayne, M.J.; Zarco, P. Intravascular ultrasound imaging of angiographically normal coronary segments in patients with coronary artery disease. Am. Heart. J., 1994, 127, 536-544. (Pubitemid 24124681)
123. Calvert, P.A.; Obaid, D.R.; O'Sullivan, M.; Shapiro, L.M.; McNab, D.; Densem, C.G.; Schofield, P.M.; Braganza, D.; Clarke, S.C.; Ray, K.K.; West, N.E.; Bennett, M.R. Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study. JACC. Cardiovasc. Imaging., 2011, 4(8), 894-901.